Diospyros is a large genus of the Ebenaceae plant family having more than 700 species distributed throughout the tropics with only few species extending into temperate regions. This genera is characterized by the presence of numerous pentacyclic triterpenes and 1,4-naphtoquinone derivatives. Other compounds can also be found such as tannins, sterols, coumarins and flavonoids [1] [2] [3] [4] . Numerous studies have endeavored to report the pharmacological potentialities by showing in particular antiviral and antibacterial activities of different species [1, 2, 5] . Different Diospyros are also used in traditional medicine [1] . In the island of New Caledonia, two species are natives and twenty-nine are endemics among them D. macrocarpa Hiern [6] . No phytochemical studies were previously conducted on this species even if a study showed interesting bioactivity of crude extracts: cytotoxicity against KB and MRC5 cell lines for the leaves and against KB cell line for the barks, antimicrobial activity against Staphylococcus aureus and Candida albicans, and enzymatic inhibition against DV2-NS5B protein [7] .
Dried leaves and barks were powdered separately and extracted successively with cyclohexane, ethyl acetate and methanol. Each extract was concentrated under reduced pressure to yield a dark green gum. Extracts were prepared for bioactivity assays by filtration on polyamine column and then tested for their cytotoxic, antimicrobial and radical scavenging activities.
Cell viabilities of normal human fibroblasts and seven cancer cell lines: HuH7 (hepatocellular carcinoma cells), CaCo-2 (colorectal adenocarcinoma), MDA-MB-231 (breast adenocarcinoma), 1278 Natural Product Communications Vol. 12 (8) 2017 Thieury et al. Table 2 : Mitotic index (MI) and percentage of proliferating cells (%S) after treatment by ethyl acetate extract from the barks of D. macrocarpa at two concentrations (C 1 ≈ IC 50 and C 2 ≈ 2 × IC 50 ) and observed variations (Δ) compared to control (DMSO at final concentration for extract). "+" if MI or %S is higher after extract treatment than control, "-" if MI or %S is lower after extract treatment than control and "0" reflects no difference between extract and control treatments. Pi-103
HCT116 (colorectal carcinoma), PC3 (prostatic adenocarcinoma), NCI-H727 (lung carcinoid), HaCaT (immortal keratinocyte), MCF-7 (breast adenocarcinoma) and RL (Non-Hodgkin's lymphoma) in the presence of filtrated extracts at a single dose of 10 μg/mL were evaluated. The percentages of cell survival (PS) after treatment by filtrated extracts were determined (data not shown). For filtrated extracts inducing a PS ≤ 50%, quantifications of the activities were performed by determining their IC 50 . This value corresponded to the concentration of a given compound inducing a PS equal to 50%. All the extracts were inactive against all the tested cell lines except the ethyl acetate extract from the bark of D. macrocarpa for which results are presented in Table 1 . This extract showed interesting activity against NCI-H727 cancer cell line with an IC 50 inferior to 10 µg/mL, especially as it was selective (inactive against healthy cell line and against the other cancer cell lines).
The mechanism of action of the ethyl acetate extract from the barks of D. macrocarpa on HuH7 and NCI-H727 cancer cells was investigated using fluorescence and immunofluorescence. The extract was tested at a concentration of IC 50 (C 1 ) and 2 × IC 50 (C 2 ) in order to observe the effects of extract without killing all the cells to obtain significant results.
First, the percentage of cell in M phase or mitotic index (MI) was measured. During mitosis, the DNA condensation process is regulated by the phosphorylation of histone H3, a DNA associated nuclear protein. The phosphor-histone H3 antibody (PHH3) is a universal marker for mitosis by detecting the phosphorylated histone. Cancer cells were labelled with Hoechst fluorescent dye and the PHH3 antibody and MI values were calculated according to the following formula:
An increase in MI compared to the control meant that cells entered into mitosis but were blocked before the end of the division. Therefore, compounds' action occurred during the M phase before the M checkpoint. A decrease of MI compared to the control meant that the cells did not enter into the M phase and consequently the compounds' action occurred before the beginning of the M phase. Second, the percentage of cells in S phase (%S) was measured. Cells were grown with bromodeoxyuridine (BrdU), a thymidine analogue that is incorporated in cells during DNA synthesis (S phase). Cancer cells were labelled with Hoechst fluorescent dye and BrdU antibody and the percentages of cells in the S phase were calculated according to the following formula:
An increase of the percentage of cells in the S phase compared to the control indicated that cells entered into DNA synthesis but were blocked before the end of the replication. Therefore, the compounds' action occurred during the S phase before the G2/M checkpoint. A decrease of the percentage of cells in the S phase compared to the control indicated that cells did not enter into the S phase indicating that the compounds' action occurred before the G1/S checkpoint. Table 2 summarized all the MI and %S of the ethyl acetate extract from the barks of D. macrocarpa.
To elucidate the phase of the cell cycle targeted by the extract, we compared the percentages of cells in the S and M phases between control and compounds after 48h-treatments. Table 2 summarizes all the observed variations (column Δ). Figure 2 gives the determination keys based on these variations and table 3 summarizes the targeted cell cycle phases. The ethyl acetate extract from the barks of D. macrocarpa led to a blocking in G1/S on both HuH7 and NCI-H727 cell lines. 
Radical scavenging activities of crude extracts were evaluated thanks to the DPPH radical scavenging assay and quantified by the determination of IC 50 of active extracts, which are summarized in Table 4 . The most active extract is the methanol extract from the leaves of D. macrocarpa with an IC 50 of 5.3 ± 0.1 μg/mL, of the same order of magnitude as that of ascorbic acid (industrial radical scavenger of reference).
Then the three extracts from the leaves of D. macrocarpa were fractionated by a sequence of chromatographic techniques to afford two new cyclobutane dimers, namely macrocarpasin A 1 and B 2 (Figure 1 ), three commonly occurring triterpenes betulinic acid 4 [8] oleanderolide 8 [9] , α-amyrin 5 [10] and β-amyrin 6 [10] , one monoterpene lactone, loliolide 7 [11] and one known kavalactone, yangonin 3 [12] . We reported for the first time the presence of a kavalactone in the Ebenaceae family. All isolated compounds were characterized by their 1D and 2D NMR spectra ( 1 H, 13 , which is only possible for a head to tail dimer. The cyclobutane moiety was confirmed by the coupling constants 1 J HC (7)=136 Hz and 1 J HC (8)=149 Hz [13] . From these results and by comparing these with the chemical shifts of the known compounds yangonin [12] and achyrodimer A [14] , the structure was concluded to be the head-tail cyclobutane dimer of yangonin (symmetry point) and named macrocarpasin B. For the macrocarpasin A (1), the positive HR-ESI-MS gave a pseudo molecular ion peak at m/z 517. only possible for a head-to-head dimer. The cyclobutane moiety was confirmed by the coupling constants 1 J HC (7)=144 Hz and 1 J HC (8)=150 Hz [13] .
From these results, the structure (1) was concluded to be the headhead cyclobutane dimer of yangonin (symmetry axis) and named macrocarpasin A.
Cell viabilities of normal human fibroblasts and the same seven cancer cell lines (HuH7, CaCo-2, MDA-MB-231, HCT116, PC3, NCI-H727 and HaCaT) in the presence of the eight isolated compounds at a single dose of 50 μM were evaluated. The PS after treatment by isolated compounds were determined. All the isolated compounds were inactive against all the tested cell lines.
During this study, we showed that extracts from leaves and barks of D. macrocarpa had no cytotoxic activity. These results were not in agreement with those previously published [7] . Indeed, the literature about D. macrocarpa showed cytotoxic activity on KB cancer cell line. However, these activities were observed on crude extracts while in this study the extracts were previously filtered on polyamine to eliminate the large polyphenolic molecules, sometimes responsible for false positives during bioactive assay. Furthermore, the extract may be selective from the KB cell line, which could explain the absence of activity on the other cell lines. Moreover, a variation in the composition of the extract due to different harvesting periods in different biotopes of D. macrocarpa could lead to the observed differences of bioactivity. We also showed that methanol extracts had interesting radical scavenging properties.
Eight compounds, of which two were new, were isolated from the leaves of D. macrocrapa. All of them were inactive against the cancer cell lines tested in this study. These results were in agreement with those previously published for the known compounds, except for betulinic acid. Indeed, data about cytotoxic effects of loliolide, α-amyrin and β-amyrin showed an inactivity, in particular on HCT116 and MCF-7 cell lines for α-amyrin and βamyrin [10, [15] [16] [17] , on MCF-7, PC3 and HCT116 cell lines of loliolide as well as weak activity of loliolide on CaCo-2 cell line [18] [19] [20] [21] . Oleanderolide and yangonin were already shown to have no cytotoxic activity but these results were obtained on different types of cancer cells than the ones used in this study [9, 22] . Betulinic acid showed no cytotoxic effects despite the many studies demonstrating its activity on a broad spectrum of cancer cells as well as studies about its mechanism of action; in particular its activity against MDA-MB-231, HCT116, PC3, MCF-7 and HaCaT cell lines with IC 50 inferior to 10 µM [23] [24] [25] [26] . These differences of activity could be explained by the differences between the protocols and in particular the disclosure principle, enzymatic by the use of MTT or by fluorescence. Betulinic acid may be responsible for enzymatic inhibition without altering cell viability.
Experimental
Plant Material: Barks and leaves of D. macrocarpa were collected at Païta, New Caledonia (GPS coordinates: S166.37, E22.13) in April 2013 under scientific authorizations (South Province N°1995-2012). Identification was confirmed by botanists and a voucher specimen (CT09) has been deposited at the Research Institute for Development of Noumea.
Extraction and Sample Preparation:
Dried, powdered leaves (682 g) and barks (282 g) of D. macrocarpa were extracted successively by solvent of increasing polarity: cyclohexane, ethyl acetate and methanol at room temperature to yield three crude extracts. For , four baths of one hour using ultrasonic were down. Extracts were filtrated on Chromabond® prepacked polyamide column to avoid false positive results due to polyphenolic compounds during cytotoxic tests. 80 to 100 mg of extract were solubilized in 10 mL 50:50 EtOAc/MeOH and then eluted with first 5 mL EtOAc and second 5 mL MeOH.
Cell Culture: Skin diploid fibroblastic cells were purchased from BIOPREDIC International Company (Rennes, FR). HuH7, Caco-2, MDA-MB-231, HCT116, PC3, HaCaT and NCI-H727 cell lines were obtained from the ECACC collection (Porton, UK). Cells were grown according to ECACC recommendations in DMEM for HuH7, MDA-MB-231, HaCaT and fibroblast, in EMEM for CaCo-2, in McCoy's for HCT116 and in RPMI for PC3 and NCI-H727 at 37°C and 5% CO 2 . All culture mediums were added with 10% of FBS, 1% of penicillin-streptomycin and 2 mM L-glutamine.
Cell Viability Assay:
Compounds were solubilized in DMSO at a concentration of 20 mg/mL. These solutions were then diluted with medium to the desired concentration while maintaining a DMSO final concentration at less than 0.25%. Cell viability assays were performed in two phases: a preliminary screening at a unique dose of each compound or extract (final well concentration 20 μg/mL for the filtrated extracts and 50 μM for the isolated compounds) and for the interesting compounds or extracts (percentage of viability < 50%), an IC 50 determination test with increasing concentrations of each extract (final well concentrations 0.08 -0.25 -0.74 -2.22 -6.67 -20 μg/mL). Roscovitine and Pi-103 were used as a positive control. Cells were plated in 96 wells at a number of 4000 cells/well except for HCT116 cell line for which 2000 cells/well were plated because of their quick growth (twice as fast). Twenty-four hours after seeding, cells were exposed to each compound. After 48h of treatment, cells were washed in PBS and fixed in cooled 95% ethanol/5% acetic acid or in 4% paraformaldehyde (60 μL during 24 minutes). Then, the nuclei were stained with Hoechst 33342 (dilution 1/1000, 1 hour). Image acquisitions and analysis were performed in 80 μL of PBS using a Cellomics ArrayScan VTI/HCS Reader (ThermoScientific). The survival percentages were calculated as the number of cells after compound treatment over the number of cells after DMSO treatment. According to dose-response curves, the IC 50 values were determined graphically, as described by the NCI [27] .
PHH3 Antibody Labeling:
After fixation, cells were co-stained with Hoescht dye and primary antibody phospho-histone H3 (Ser10) (dilution 1/5000, 2 hours), and then with secondary coupled-fluorophore antibody detecting primary antibody (dilution 1/500, 1 hour). The mitotic index was calculated as the number of mitotic cells, identified by the PHH3-positive staining over the total Hoechst positive cells.
BrdU Incorporation: Before fixation, BrdU was added to the culture medium for 90 minutes at 37°C and 5% CO 2 (dilution 1/1000 during 30 minutes). After fixation, cells were co-stained with Hoescht dye and BrdU primary antibody (dilution 1/200, 2 hours) and then with secondary coupled-fluorophore antibody detecting primary antibody (dilution 1/500, 1 hour). The percentage of proliferating cells was calculated by the amount of BrdU positive cells over the total Hoechst positive cells.
Radical Scavenging Assay:
The scavenging activity against DPPH radicals was monitored according to the method of Kano [28] with some modifications. Briefly, 20 μL of extract solutions at various concentrations (0.1 to 5 mM) were added to 180 μL of a 100 μM solution of DPPH in 50% water and 50% ethanol. After a 30 min incubation period at room temperature, the absorbance was read against a blank at 517 nm. Ascorbic acid was used as a positive control. Inhibition of free radical by DPPH in percent (I%) was calculated thanks to the following formula:
To quantify the activities, extract concentrations providing 50% inhibition (IC 50 ) were calculated from the dose-effect curves. Tests were carried out in triplicate.
Isolation from the Leaf Extracts:
The cyclohexane extract afforded three fractions on a silica gel CC using C 6 H 12 :EtOAc (0:100, 75:25 and 100:0). The third one was subjected to silica gel CC, eluted with C 6 H 12 :CH 2 Cl 2 (90:10, 80:20, 70:30, 60:40, 30:70 and 0:100) to yield 6 fractions. The third one was purified by preparative TLC using C 6 H 12 :CH 2 Cl 2 (50:50) and yielded to a mixture of 1 (50%), 2 (10%) and 3 (40%).
The ethyl acetate extract was extracted with CH 2 Cl 2 . The soluble fraction was purified on silica gel CC using CH 2 Cl 2 :EtOAc (100:0, 80:20, 50:50, 20:80 and 0:100), yielded 4 and 7 other fractions. The seventh one was purified over silica gel CC using CH 2 Cl 2 :EtOAc (100:0, 90:10, 75:25 and 0:100) to yield 4 fractions which the third one were fractionated on a silica gel CC using CH 2 Cl 2 :EtOAc (100:0, 95:5, 90:10, 85:15, 75:25, 50:50 and 0:100) to afford a mixture of 5 (66%) and 6 (30%) as well as 6 other fractions. The soluble-ACN part of the fifth fractions was fractionated by HPLC using a gradient of water and ACN (50% to 100% of ACN) to yield 7 and 8. Fractionation by HPLC was done on a Waters 2695 Separation module coupled with a Waters 2996 photodiode array detector. The column used was a NUCLEODUR® 100-5 C18ec (250/4.6).
Chemicals:
Hoescht 33342 reagent was purchased from Sigma-Aldrich (Saint-Louis, MO, USA) as were paraformaldehyde, DPPH, ascorbic acid McCoy's, EMEM and RPMI. Bromodeoxyuridine (BrdU) was purchased from Amersham (Buckinghamshire, UK), BrdU primary antibody from Abcam (Cambridge, UK), phosphohistone H3 (PHH3) antibody from Millipore (Molsheim, FR). Secondary coupled-fluorophore antibodies were purchased from KPL (Gaithersburg, MD, USA). Roscovitine and Pi103, PBS and DMEM, L-glutamine were purchased from Gibco (Carlsbad, CA, USA). Foetal Bovine Serum (FBS) was purchased from GE Healthcare (Little Chalfont, UK) and penicillin-streptomycin from Life technologies (Carlsbad, CA, USA).
Compound Characterization:
High-resolution electrospray ionization mass spectrometry (HR-ESI-MS, HR-ESI-MS/MS) analyses were carried on a Waters SYNAPT G2 HDMS instrument equipped with an atmospheric pressure ionization source. NMR experiments were performed using a Bruker Avance III 600 spectrometer ( 1 H 600.13 MHz) equipped with a Bruker 5 mm BBFO+ probe at 300 K. All spectra were acquired in CDCl 3 -99.80%-d (δ 1H =7.26 ppm, δ 13C =77.16 ppm). Standard pulse sequence and parameters were used to obtain 1 H, 13 C-DEPTQ135, COSY, HSQCed, HMBC, NOESY (all spectral data were added as supplementary data). 
